# Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients

> **NCT01989910** · PHASE4 · COMPLETED · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 107 (actual)

## Conditions studied

- HIV-1 Infection

## Interventions

- **DRUG:** Raltegravir
- **DRUG:** Efavirenz

## Key facts

- **NCT ID:** NCT01989910
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2015-12
- **Final completion:** 2017-12
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2019-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01989910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01989910, "Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01989910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*